STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
STAT News · LC · trust 35/100
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use.
Read the original at STAT News →
Open in TruthVane →